IRWD EBITDA Margin
Ironwood Pharma Inc Class A · EBITDA Margin
IRWD EBITDA Margin
Latest reported62.13%period ending
IRWD TTM EBITDA Margin (-178.41% → 62.13%)
TTM ebitda margin
High-resolution chart · PNG
IRWD ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 62.1287% | |
| 57.2954% | |
| 41.2982% | |
| 43.3344% | |
| 31.5261% | |
| 24.3868% | |
| 28.3176% | |
| 28.1829% | |
| 30.3651% | |
| 36.5302% | |
| 46.704% | |
| 55.5931% | |
| 63.1648% | |
| 64.7166% | |
| 63.6728% | |
| 57.5162% | |
| 56.668% | |
| 57.8531% | |
| 55.9152% | |
| 55.7233% | |
| 51.6965% | |
| 45.5466% | |
| 37.5462% | |
| 37.2247% | |
| 31.3673% | |
| 28.0445% | |
| 23.5343% | |
| 9.3192% | |
| -42.4607% | |
| -54.7092% | |
| -59.5576% | |
| -56.5008% | |
| -9.785% | |
| -17.2449% | |
| -22.1104% | |
| -33.2405% | |
| -35.2397% | |
| -27.2707% | |
| -11.4233% | |
| -12.4835% | |
| -21.7981% | |
| -41.3361% | |
| -68.0111% | |
| -96.0081% | |
| -114.5173% | |
| -155.2461% | |
| -205.347% | |
| -392.5474% | |
| -605.8393% | |
| -570.5413% | |
| -1,049.4777% | |
| -529.9398% | |
| -97.9019% | |
| -80.9822% | |
| -40.802% | |
| -15.7574% | |
| -132.534% | |
| -106.7499% | |
| -84.963% | |
| -123.5754% | |
| -121.9184% | |
| -122.3297% | |
| -118.5267% | |
| -177.4858% | |
| -135.8497% | |
| -154.2545% | |
| -182.3007% | |
| -178.4142% |